Biotech - Press Releases

Date	Title	Company
02-Jan-2020	BioMarin Announces New England Journal of Medicine Publishes 3 Years of Follow-up Data in Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A	BioMarin Pharmaceutical Inc.
02-Jan-2020	Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China	Amgen
02-Jan-2020	Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus	Intrexon Corporation
02-Jan-2020	Caris Life Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference	Caris Life Sciences
02-Jan-2020	Antabio Awarded $4.4 Million from CARB-X for the Further Development of its New Treatment for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients	Antabio SAS
02-Jan-2020	Long-Term Effects of PectaSol-C Modified Citrus Pectin Against Biochemically Relapsed Prostate Cancer--Updated Results from a Phase IIb Clinical Trial	Better Health Publishing
02-Jan-2020	WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392	WuXi Biologics
31-Dec-2019	Invitae to Present at the 38th Annual J.P. Morgan Healthcare Conference	Invitae Corporation
30-Dec-2019	Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.	Janssen Pharmaceutical Companies of Johnson & Johnson
30-Dec-2019	Novadoz Pharmaceuticals/MSN Labs is granted FDA Approval of generic Febuxostat Tablets, begins immediate shipping	Novadoz Pharmaceuticals
30-Dec-2019	FDA In Brief: FDA provides additional information about requirements for dual column labeling, serving sizes on Nutrition Facts label	U.S. Food and Drug Administration
30-Dec-2019	Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan® System	Check-Cap Ltd.
29-Dec-2019	Creative Diagnostics Launches Hepatitis B Virus Surface Antigen Mutants for Bio-research	Creative Diagnostics
27-Dec-2019	Stryker launches voluntary field action for specific units of the LIFEPAK® 15 monitor/defibrillator	Stryker
27-Dec-2019	Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.	Astellas
26-Dec-2019	OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999	OBI Pharma, Inc.
25-Dec-2019	Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development	bioLIVE China
24-Dec-2019	PharmaForce International: Unique Sales Force Trends in the EU5 Biosimilar Market	PharmaForce International
24-Dec-2019	PharmaLink Announces Facility Expansion to Accommodate Growth	PharmaLink
24-Dec-2019	Pharmaceutical Contract Manufacturing Market	Fior Market Research LLP